Displaced Students in Nigeria

Displaced Students in Nigeria

Top of Mind with Julie Rose - Radio Archive, Episode 197 , Segment 5

Episode: Religion and Globalization, Math Stories, Car Crash Risks, Nigeria

  • Dec 15, 2015 10:00 pm
  • 15:24 mins

Guest: Michael Zamba, Senior Director of Communications at Creative Associates International The terror group Boko Haram – which is now affiliated with ISIS – has wrought so much havoc in parts of Nigeria that some 2.2 million people have fled their homes and villages. Many of these internally-displaced refugees are children who have lost family members and the stability of their former lives. For them, the opportunity to spend a few hours a week in a classroom learning basic math and language skills is not just a diversion; it’s a refuge.

Other Segments

Medical Side Effects on Women

19m

Guest: Alyson McGregor, MD, Associate Professor of Emergency Medicine at Brown University, Director for the Division of Sex and Gender in Emergency Medicine, Attending Physician at Rhode Island Hospital, Co-founder of the Sex and Gender Women’s Health Collaborative When your doctor says, something like “this medicine has been shown to work well in 60% of patients,” you probably think – “Well, hey, I’ve got a pretty good chance it’ll work well for me.” But, now let’s say you’re a woman and the doctor said, “this medicine has been shown to work well in 60% of men.” Then you’d be thinking – yeah, and…what about women? And here’s the thing – your doctor probably won’t have the answer. Because, drugs are mainly tested on men – or cells that came from men. It’s been that way for decades, but there is growing interest in addressing “gender blindness” in the drug mark

Guest: Alyson McGregor, MD, Associate Professor of Emergency Medicine at Brown University, Director for the Division of Sex and Gender in Emergency Medicine, Attending Physician at Rhode Island Hospital, Co-founder of the Sex and Gender Women’s Health Collaborative When your doctor says, something like “this medicine has been shown to work well in 60% of patients,” you probably think – “Well, hey, I’ve got a pretty good chance it’ll work well for me.” But, now let’s say you’re a woman and the doctor said, “this medicine has been shown to work well in 60% of men.” Then you’d be thinking – yeah, and…what about women? And here’s the thing – your doctor probably won’t have the answer. Because, drugs are mainly tested on men – or cells that came from men. It’s been that way for decades, but there is growing interest in addressing “gender blindness” in the drug mark